Abstract
The firing activity of suprachiasmatic nuclei (SCN) neurones in vitro shows a circadian rhythm with the peak in average firing frequency during the middle of the projected day. Vasoactive intestinal polypeptide (VIP), which is abundant in the rat SCN, phase-advances the time of peak in SCN neuronal activity when applied in vitro during the late projected night; an effect most likely mediated via the VPAC 2 receptor. Employing extracellular single-unit electrophysiology, we investigated the influence of protein kinase A (PKA) inhibitor KT5720 or mitogen-activated protein kinase kinase (MAPKK) inhibitor U0126 on phase advances evoked during the late projected night by VIP or Ro 25-1553, a VPAC 2 receptor agonist. Both inhibitors blocked VIP or Ro 25-1553-induced phase advances, indicating that the late-night resetting actions of VIP via the VPAC 2 receptor require PKA and MEK.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
